Progressive pulmonary fibrosis (PPF) is an increasingly recognised condition, defined in 2022 to address the progression of ...

Hosted by Boehringer Ingelheim, the ‘CRM Summit’, an expert engagement forum, and the ‘IMETA CRM Discussions for EXperts (MEDEX CRM)’, a scientific expert meeting, brought together healthcare ...

The Progressive Fibrosing Interstitial Lung Disease (PF-ILD) market is currently valued at USD 4,742.2 Million in 2023 and is ...

Bayer and Boehringer Ingelheim both had new data on their HER2-targeting small-molecule drugs to present at the World Conference on Lung Cancer (WCLC), hoping to add new oral therapies to the ...

Boehringer Ingelheim has taken an option on a family of compounds with potential as therapies for schizophrenia from Sosei Heptares, which it says could have broad activity against the symptoms of ...

The global Cattle & Porcine/Swine Reproductive Diseases market is expected to grow to USD 975.8 Million by 2029, up from USD ...

With millions of U.S. voters already heading to the polls, Democratic presidential candidateKamala Harris on Wednesday will seek support from undecided voters at a televised town hall in ...

Liberty Media Corp. Series C Liberty Formula One 1.19% $23.46B Liberty Media Corp. Series A Liberty Formula One 1.09% $23.46B Liberty Broadband Corp. Cl A 4.70% $11.06B Liberty Broadband Corp. Cl ...

The hidradenitis suppurativa (HS) treatment market is set to surpass USD 763.6 million in 2023 and is projected to reach an ...

The global Progressive Pulmonary Fibrosis (PPF) Treatment Market is set to achieve a valuation of USD 3.72 million in 2023, ...